ES553874A0 - Un procedimiento para la preparacion de metanosulfonatos de dioxolano. - Google Patents

Un procedimiento para la preparacion de metanosulfonatos de dioxolano.

Info

Publication number
ES553874A0
ES553874A0 ES553874A ES553874A ES553874A0 ES 553874 A0 ES553874 A0 ES 553874A0 ES 553874 A ES553874 A ES 553874A ES 553874 A ES553874 A ES 553874A ES 553874 A0 ES553874 A0 ES 553874A0
Authority
ES
Spain
Prior art keywords
methanosulphonates
dioxolane
procedure
preparation
dioxolane methanosulphonates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553874A
Other languages
English (en)
Other versions
ES8801242A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho McNeil Pharmaceutical Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of ES553874A0 publication Critical patent/ES553874A0/es
Publication of ES8801242A1 publication Critical patent/ES8801242A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
ES553874A 1985-04-12 1986-04-10 Un procedimiento para la preparacion de metanosulfonatos de dioxolano. Expired ES8801242A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/722,869 US4591601A (en) 1985-04-12 1985-04-12 Anticonvulsant dioxolane methane sulfamates

Publications (2)

Publication Number Publication Date
ES553874A0 true ES553874A0 (es) 1988-01-01
ES8801242A1 ES8801242A1 (es) 1988-01-01

Family

ID=24903753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553874A Expired ES8801242A1 (es) 1985-04-12 1986-04-10 Un procedimiento para la preparacion de metanosulfonatos de dioxolano.

Country Status (9)

Country Link
US (1) US4591601A (es)
EP (1) EP0198686A3 (es)
JP (1) JPS61263973A (es)
AU (1) AU579463B2 (es)
CA (1) CA1252109A (es)
DK (1) DK167586A (es)
ES (1) ES8801242A1 (es)
GR (1) GR860953B (es)
ZA (1) ZA862744B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792569A (en) * 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5273993A (en) * 1989-06-12 1993-12-28 A. H. Robins Company, Incorporated Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
US5194446A (en) * 1989-06-12 1993-03-16 A. H. Robins Company, Incorporated Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
US5192785A (en) * 1989-09-03 1993-03-09 A. H. Robins Company, Incorporated Sulfamates as antiglaucoma agents
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
IL140861A (en) * 1998-07-15 2004-06-01 Bristol Myers Squibb Co Dioxolane pentanoic acid and processes for the preparation thereof
US7335650B2 (en) * 2000-01-14 2008-02-26 Sterix Limited Composition
US7422775B2 (en) * 2005-05-17 2008-09-09 Applied Materials, Inc. Process for low temperature plasma deposition of an optical absorption layer and high speed optical annealing
US20090318520A1 (en) 2008-06-20 2009-12-24 Afecta Pharmaceuticals Drive Use of isoindoles for the treatment of neurobehavioral disorders
WO2013187727A1 (en) 2012-06-15 2013-12-19 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
US9937145B2 (en) 2013-12-12 2018-04-10 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compound for use in preventing or treating epilepsy
ES2704928T3 (es) 2013-12-12 2019-03-20 Bio Pharm Solutions Co Ltd Compuestos derivados de sulfamato para su uso en el tratamiento o alivio del dolor
EP3079687B1 (en) * 2013-12-12 2018-02-28 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compounds for use in treating or alleviating pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058981A (en) * 1958-11-14 1962-10-16 Richardson Merrell Inc 2-methyl-2-nonyl-4-hydroxymethyl-1, 3-dioxolane and carbamates thereof
DE1131226B (de) * 1958-12-24 1962-06-14 Riedel De Haeen Ag Verfahren zur Herstellung der Carbaminsaeureester von 4-Oxymethyl-1,3-dioxolanen
BE622353A (es) * 1961-09-15
US3948953A (en) * 1969-08-05 1976-04-06 Texaco Inc. Dioxolane derivatives having surfactant properties
US3997585A (en) * 1974-12-30 1976-12-14 Ortho Pharmaceutical Corporation Aliphatic sulfamates
IL59407A (en) * 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
JPS57197258A (en) * 1981-05-29 1982-12-03 Taiho Yakuhin Kogyo Kk Sulfonic ester derivative and its preparation

Also Published As

Publication number Publication date
AU579463B2 (en) 1988-11-24
DK167586D0 (da) 1986-04-11
DK167586A (da) 1986-10-13
GR860953B (en) 1986-08-06
EP0198686A2 (en) 1986-10-22
ZA862744B (en) 1987-11-25
ES8801242A1 (es) 1988-01-01
CA1252109A (en) 1989-04-04
US4591601A (en) 1986-05-27
AU5601086A (en) 1986-10-16
EP0198686A3 (en) 1987-10-21
JPS61263973A (ja) 1986-11-21

Similar Documents

Publication Publication Date Title
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES556550A0 (es) Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES552297A0 (es) Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES553874A0 (es) Un procedimiento para la preparacion de metanosulfonatos de dioxolano.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES555369A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES553283A0 (es) Un procedimiento para la preparacion de 2-amino-6-cloropurina.
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES555723A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603